Independent Advisor Alliance Purchases New Holdings in Omada Health, Inc. $OMDA

Independent Advisor Alliance bought a new stake in shares of Omada Health, Inc. (NASDAQ:OMDA) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 45,426 shares of the company’s stock, valued at approximately $717,000. Independent Advisor Alliance owned approximately 0.08% of Omada Health as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. BIT Capital GmbH purchased a new stake in shares of Omada Health during the third quarter valued at approximately $13,639,000. Divisadero Street Capital Management LP bought a new position in Omada Health in the 3rd quarter valued at approximately $30,510,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Omada Health in the 4th quarter worth $1,222,000. Fortress Investment Group LLC raised its stake in shares of Omada Health by 43.1% in the third quarter. Fortress Investment Group LLC now owns 225,000 shares of the company’s stock worth $4,975,000 after purchasing an additional 67,750 shares during the last quarter. Finally, Tudor Investment Corp ET AL bought a new position in shares of Omada Health during the third quarter valued at $987,000.

Insider Activity at Omada Health

In other Omada Health news, CEO Sean P. Duffy sold 4,063 shares of the company’s stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $14.34, for a total transaction of $58,263.42. Following the completion of the sale, the chief executive officer directly owned 117,598 shares of the company’s stock, valued at approximately $1,686,355.32. This represents a 3.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Steven L. Cook sold 1,884 shares of the stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average price of $13.94, for a total transaction of $26,262.96. Following the completion of the transaction, the chief financial officer owned 200,512 shares in the company, valued at $2,795,137.28. The trade was a 0.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 8,776 shares of company stock worth $120,483. 6.38% of the stock is owned by company insiders.

Omada Health Stock Performance

OMDA stock opened at $16.56 on Friday. The company has a market cap of $984.49 million and a price-to-earnings ratio of -61.33. The business’s 50-day moving average is $13.89 and its two-hundred day moving average is $15.51. Omada Health, Inc. has a fifty-two week low of $10.28 and a fifty-two week high of $28.40.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The business had revenue of $78.05 million during the quarter. Equities analysts predict that Omada Health, Inc. will post -0.04 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently commented on OMDA. Needham & Company LLC reiterated a “buy” rating and issued a $28.00 price objective on shares of Omada Health in a report on Friday, May 8th. Citizens Jmp raised their price target on shares of Omada Health from $18.00 to $21.00 and gave the company a “market outperform” rating in a report on Friday, May 8th. Morgan Stanley reduced their price target on shares of Omada Health from $32.00 to $30.00 and set an “overweight” rating for the company in a research note on Friday, March 6th. Weiss Ratings reissued a “sell (d)” rating on shares of Omada Health in a report on Thursday, January 22nd. Finally, Canaccord Genuity Group set a $24.00 target price on shares of Omada Health in a report on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $22.91.

Omada Health Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.